M Torreggiani, S Blanchi, A Fois, H Fessi… - Kidney …, 2021 - ncbi.nlm.nih.gov
Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately …
M Torreggiani, S Blanchi, A Fois, H Fessi… - Kidney International, 2021 - cir.nii.ac.jp
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won | CiNii Research CiNii 国立 …
M Torreggiani, S Blanchi, A Fois… - Kidney …, 2021 - pubmed.ncbi.nlm.nih.gov
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won Neutralizing SARS-CoV-2 …
M Torreggiani, S Blanchi, A Fois, H Fessi… - Kidney …, 2021 - europepmc.org
On December 21, 2020, the European Commission granted conditional marketing approval to the BNT162b2 coronavirus disease 2019 (COVID-19) mRNA vaccine developed by …
M Torreggiani, S Blanchi, A Fois, H Fessi… - Kidney …, 2021 - europepmc.org
Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately …